香港股市 已收市

Blau Farmacêutica S.A. (BLAU3.SA)

São Paulo - São Paulo 延遲價格。貨幣為 BRL。
加入追蹤清單
24.70+0.81 (+3.39%)
收市價: 05:06PM BRT

Blau Farmacêutica S.A.

Rodovia Raposo Tavares, 2833, km 30,5
Barro Branco
Cotia, SP 06705-030
Brazil
55 11 4615 9400
https://www.blau.com

版塊Healthcare
行業Drug Manufacturers—Specialty & Generic
全職員工

高階主管

名稱標題支付行使價出生年份
Mr. Marcelo Rodolfo HahnFounder, CEO & Deputy Chairman
Claudio GomesChief Financial Officer
Mr. Roberto Carlos de Campos MoraisCOO & Director
Mr. Roberto AltieriLegal & Compliance Officer
截止 為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 BRL。

描述

Blau Farmacêutica S.A., a pharmaceutical company, engages in the manufacture, development, and commercialization of private label drugs in Brazil, Colombia, Uruguay, Chile, and internationally. It operates through Institutional and Retail segments. The company's medications cover various therapeutic classes, such as immunology, hematology, oncology, nephrology, specialties, and antibiotics. It offers biological drugs; oral and injectable drugs for treating cancer; specialized treatments for infectious diseases; and prescription and non-prescription over-the-counter drugs, including dermo-medicines, condoms, and others for retail and non-retail markets. The company's products also comprise uterine stimulator, antibiotics, feminine health care, biopharmaceuticals, essential hospital products, antivirals and antiretrovirals, biosimilars, acid pump inhibitor, hemoderivados, antithrombotic, and trombolíticos. It serves public and private hospitals, and clinics; and pharmaceutical retail channels. The company was incorporated in 1987 and is headquartered in Cotia, Brazil.

公司管治

截至 無 止,Blau Farmacêutica S.A. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。